Pancreatic cancer is one of the most aggressive cancers in the world. Due to a poor prognosis and the lack of specific biomarkers, 94% of pancreatic cancer cases lead to patient death [1]. Most of the time pancreatic cancer is diagnosed in an advanced stage. As surgical resection is then impossible, chemotherapy becomes the only hope for the patient. Gemcitabine is a classical pancreatic cancer chemotherapeutic, however, development of resistance is almost inevitable [2]. For this reason, new combination therapies are constantly under development.
In 2012, scientists discovered a new iron-dependent cell death form, ferroptosis [3], which is caused by an excessive membrane lipid peroxidation. Iron mediated Fenton reactions constantly generate lipid peroxides. Normally, to prevent oxidative damage, cells activate lipid antioxidant glutathione peroxidase 4 (GPX4). Ferroptosis inducers inhibit activity or expression of GPX4, which leads to accumulation of harmful lipid peroxides and eventual cell death. It was shown that cancer cells are especially sensitive to ferroptosis inducers, as they have more cytosolic iron in comparison to their normal counterparts. Thus, ferroptosis can be successfully targeted to different types of cancer cells, including pancreatic [4]. Another emerging anticancer strategy is starvation based therapy. It includes various methods: blocking angiogenesis, enhancing intratumoral nutrient catabolism and treatment with compounds that mimic starvation, such as inhibitors of growth factor receptors and mammalian target of rapamycin (mTOR) pathway [5].
In this study, we explored a novel anticancer approach: ferroptosis induction combined with cell starvation. In our experiments, we used pancreatic cancer cell lines Miapaca-2, Panc-1, Su.86.86, T3M4, as well as a unique cell line Capan-26, previously established in our laboratory [6]. We showed that in these pancreatic cancer cell lines sensitivity to ferroptosis is regulated by cell starvation-induced changes of ERK1/2 and JNK kinase activation. Also, in some of the lines used, growth factor starvation made cells alternate between epithelial and mesenchymal states. We found out that compounds targeting epithelial-to-mesenchymal transition (EMT)-related signaling pathways enhance ferroptotic cell death and therefore prove to be useful for pancreatic cancer treatment. In this way, our study elucidates new prospects of combination therapy using ferroptosis inducers and kinase inhibitors.